UK: A recent systematic review published in Clinical Rheumatology has investigated the potential of botulinum toxin (BTX) as ...

Dupilumab is under clinical development by Regeneron Pharmaceuticals and currently in Phase II for Systemic Sclerosis (Scleroderma). According to GlobalData, Phase II drugs for Systemic Sclerosis ...

Treatment of scleroderma still faces many challenges ... to establish standardized systems for exosome preparation and quality control, laying the foundation for advancing the clinical application of ...

Diffuse scleroderma (extensive skin thickening proximal to the elbows and knees along with internal organ involvement) Scleroderma sine sclerosis (Raynaud's phenomenon and internal involvement ...

Scleroderma is an autoimmune connective-tissue disease whose hallmark is excessive collagen deposited around capillaries and in affected tissues, such as the skin, lungs, kidneys, and esophagus ...

CABA-201 is under clinical development by Cabaletta Bio and currently in Phase II for Systemic Sclerosis (Scleroderma). According to GlobalData, Phase II drugs for Systemic Sclerosis (Scleroderma) ...